Announcements

In light of recent regulatory developments, it is essential for stakeholders in the tissue banking community to stay informed about potential changes to FDA guidance documents.

On January 6, 2025, the FDA released six guidance documents, including two final documents: Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by HCT/Ps (Sepsis guidance) and Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by HCT/Ps (Mtb guidance).

AATB has led the drafting of a letter to the Department of Health and Human Services Transition Team for President-elect Donald Trump, joined by AOPO and EBAA, to urge the immediate rescission of two FDA guidance documents released on January 6, 2025.

As we begin the new year, we encourage all our members—Accredited Establishments and their employees, Self-Paying Individual Members, and Affiliate Members—to explore and maximize the many benefits your AATB membership offers.

On January 6, 2025, the FDA published 6 guidance documents that will affect AATB tissue establishments.

The US House of Representatives passed H.R. 7188, the Shandra Eisenga Human Cell and Tissue Product Safety Act, by voice vote this week. Sponsored by Reps.

We are excited to announce the 2025 AATB Webinar Series subscription, your gateway to year-long professional growth and education in tissue banking.

The American Association of Tissue Banks (AATB) and the AATB Tissue Policy Group are excited to invite AATB members to participate in our Capitol Hill Fly-In on February 4, 2025.

Thank you to everyone who completed the 2024 Member Satisfaction Survey!